Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.6264
+0.0093 (1.51%)
At close: Nov 18, 2025, 4:00 PM EST
0.6264
0.00 (0.00%)
After-hours: Nov 18, 2025, 4:10 PM EST
Rallybio Market Cap
Rallybio has a market cap or net worth of $26.46 million as of November 18, 2025. Its market cap has decreased by -38.08% in one year.
Market Cap
26.46M
Enterprise Value
-33.05M
1-Year Change
-38.08%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $26.46M, a decrease of -93.48%. That is a compound annual growth rate of -46.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 26.07M | -34.55% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 922.29B |
| Johnson & Johnson | 481.86B |
| AbbVie | 413.34B |
| UnitedHealth Group | 284.05B |
| AstraZeneca | 277.65B |
| Novartis AG | 244.75B |
| Merck & Co. | 239.34B |
| Abbott Laboratories | 226.05B |